Oncology Institute (NASDAQ:TOI) Posts Quarterly Earnings Results

Oncology Institute (NASDAQ:TOI) posted its quarterly earnings data on Monday. The company reported ($0.14) EPS for the quarter, Zacks reports. Oncology Institute had a negative net margin of 17.63% and a negative return on equity of 186.83%.

Oncology Institute Stock Performance

NASDAQ TOI opened at $1.00 on Monday. Oncology Institute has a fifty-two week low of $0.13 and a fifty-two week high of $1.89. The firm has a market capitalization of $75.27 million, a P/E ratio of -1.28 and a beta of 0.41. The stock’s fifty day moving average is $0.78 and its two-hundred day moving average is $0.45. The company has a debt-to-equity ratio of 5.91, a quick ratio of 2.27 and a current ratio of 2.49.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.